H
Hypervision Surgical
Health Tech & Medtech · London, United Kingdom · Founded 2021
AI-powered hyperspectral imaging for real-time surgical guidance MoreLess
Hypervision Surgical Limited is a medical technology company that provides an advanced surgical imaging and data analytics platform. The company was founded in 2020 as a spin-out from King's College London by a team of clinicians and experts in medical imaging and artificial intelligence, including CEO Michael Ebner, CSO Tom Vercauteren, Clinical Lead Jonathan Shapey, and Board Director Sebastien Ourselin.
The core of its offering is the HYPERSNAP® Surgical System, which combines hyperspectral imaging (HSI) and artificial intelligence to provide real-time, computer-assisted tissue analysis during surgery. This technology makes invisible tissue characteristics visible to the surgeon without the need for contact or contrast agents. The system is capable of wide-field tissue differentiation to identify tumors, normal tissue, and critical structures like nerves and blood vessels, and can assess tissue perfusion. The goal is to improve surgical precision, speed, and patient safety by providing surgeons with objective, data-driven information for better decision-making.
The company's business model focuses on creating a hardware-agnostic software solution that can integrate into existing surgical workflows, including minimally invasive, robotic, and microscopic surgeries. Having secured U.S. FDA 510(k) clearance and UKCA marking for its system, Hypervision Surgical is targeting the healthcare market in Europe and the United States. It is conducting clinical evaluation studies in colorectal and neurosurgery. In June 2023, the company raised £6.5 million in an oversubscribed seed funding round led by HERAN Partners, Redalpine, LifeX Ventures, and ZEISS Ventures to accelerate development and regulatory clearance.
Keywords: surgical imaging, hyperspectral imaging, artificial intelligence, medical device, real-time tissue analysis, surgical guidance, computer-assisted surgery, tissue differentiation, surgical precision, MedTech, neurosurgery, colorectal surgery, intraoperative imaging, surgical intelligence, perfusion assessment, non-invasive imaging, optical imaging, surgical data analytics
Company overview
Hypervision Surgical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- London, United Kingdom
- Employees
- 28
- Open positions
- 11
- Dealroom signal
- 90.8
Valuation & funding
Hypervision Surgical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2026 | $22M | $90M | IP Group · Angelini Ventures · ZEISS Ventures · Heal capital | ↗ |
| GRANT✓Other financing | Oct 2024 | $462K | — | UK Research and Innovation | — |
| SEED✓Equity / VC | Jun 2023 | $8.6M | $34M | Redalpine · LifeX Ventures · Zeiss · HERAN Partners | ↗ |
| SPINOUT✓Other financing | Jan 2021 | $0 | — | King's College London | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 28 |
| 2025 | 22 |
| 2024 | 21 |
| 2023 | 17 |
| 2022 | 10 |
Growth signals
Hypervision Surgical website traffic
Latest recorded traffic for Hypervision Surgical is 4.5K monthly website visits, up 60.7% over the last three months. Hypervision Surgical's team grew 27.3% over the past year.
Hiring
Open positions at Hypervision Surgical
Current openings linked to this company in Dealroom.
Comparisons
Hypervision Surgical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Cydar MedicalAI-powered surgical intelligence maps for endovascular procedures |
Cambridge, United Kingdom | Operational | 39 | $37M | $62M |
UltromicsAI-powered echocardiogram analysis for heart failure detection. |
Oxford, United Kingdom | Operational | |||
OptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management |
Oxford, United Kingdom | Operational | |||
PicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning |
Oxford, United Kingdom | Operational | |||
Kheiron Medical TechnologiesHelps radiologists detect breast cancer earlier using deep learning |
London, United Kingdom | Acquired | |||
Skin AnalyticsAI medical device for skin cancer pathways. |
London, United Kingdom | Operational | |||
Odin VisionAI-powered software for cancer detection in endoscopy. |
London, United Kingdom | Acquired | |||
EnAcuityAI-powered, software-only hyperspectral surgical imaging |
London, United Kingdom | Operational |
Talent graph
Hypervision Surgical's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Hypervision Surgical has talent and traffic
team presence
In the news
Latest news about Hypervision Surgical
Recent press, funding announcements, and product moves mentioning Hypervision Surgical — open to read from the original sources.
Market sentiment
What the market is saying about Hypervision Surgical
An AI-synthesized read of the highest-engagement posts about Hypervision Surgical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hypervision Surgical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






















